Position in PHAR
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$12,084
-$2,392 QoQ
Shares Held
870
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#9
of 17 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PHAR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Nalls Sherbakoff Group, LLC holds $12,247 across 2 Biotechnology names. PHAR ranks #1 (98.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PHAR |
Pharming Group N.V.
This page
|
870 | $12,084 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
3 | $163 |
All Filings in PHAR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,084 | 870 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $14,476 | 870 | Shares | Sole | 2026-08-17 | |
| 2025-12-31 | $15,372 | 870 | Shares | Sole | 2026-03-12 | |
| 2025-09-30 | $12,615 | 870 | Shares | Sole | 2026-03-12 | |
| 2025-06-30 | $9,300 | 870 | Shares | Sole | 2026-03-12 | |
| 2025-03-31 | $7,278 | 870 | Shares | Sole | 2026-03-12 | |
| No filing history on record for this holder in this stock. | ||||||